Long COVID’s high variability between individuals makes it especially hard to study, but machine learning could change that.
Long COVID continues to challenge researchers as they grapple to understand how and why it happens. This is particularly perplexing in people who develop new and sometimes disabling symptoms after recovering from mild COVID-19, or who were even asymptomatic. Long COVID’s high variability from person to person, along with the millions of people now living with it—knowingly or unknowingly–make it extremely difficult to trace common factors of vulnerability.
On the National Institutes of Health (NIH) Director’s Blog, Lawrence Tabak, D.D.S., Ph.D. points to a new NIH-funded study that may help researchers find answers.*
In Lancet Digital Health, a team of researchers led by Emily R. Pfaff, Ph.D., M.S. of the University of North Carolina Chapel Hill School of Medicine, and Melissa A. Haendel, Ph.D. of the University of Colorado Anschutz Medical Campus, Aurora, made a groundbreaking discovery.
They found that a computer algorithm could reliably scan tens of thousands of electronic health records (EHRs) and identify those with Long COVID. While still preliminary, the research suggests that machine learning could help determine whether someone with COVID-19 is at risk for Long COVID.
Machine learning involves finding patterns by sorting through vast amounts of data. Machine learning can identify fine data patterns that people might overlook, because it doesn’t require humans to tell it what traits to search for.
The researchers created an algorithm to search de-identified EHRs from COVID-19 patients included in the NIH”s National COVID Cohort Collaborative (N3C), a part of NIH’s RECOVER initiative (Researching COVID to Enhance Recovery) for better understanding Long COVID.
Several machine learning models were created:
The algorithm proved highly accurate (85%) at finding patients with potential Long COVID. Important features from EHRs included healthcare use, age, and breathlessness (dyspnea), among others.
Tabak explains that once people with Long COVID can be identified from a large patient registry, researchers can start looking at differences in risk factors or treatments that might reveal why Long COVID happens in one person and not the next.
The study also highlights N3C’s usefulness for more effective study of COVID-19 and its long-term effects. It makes strides toward meeting RECOVER’s “urgent goal” of identifying people with Long COVID, or at risk for the condition, who may be eligible for new treatment studies.
Tabak encourages people to enroll in RECOVER “to help researchers solve this puzzle.”
*Tabak, L. (2022, June 7). Using AI to Advance Understanding of Long COVID Syndrome. NIH Director’s Blog. https://directorsblog.nih.gov/2022/06/07/using-artificial-intelligence-to-advance-understanding-of-long-covid-syndrome
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
Add Comments
Cancel